Latest financial market updates and expert analysis
Analysis The biopharmaceutical company Viking Therapeutics finds itself at a pivotal operational crossroads. While it has laid extensive industrial groundwork for a 2026 commercial launch, recent analyst caution highlights the clinical...
The ambitious financial targets set by Adidas CEO Björn Gulden have encountered significant obstacles, prompting the Herzogenaurach-based sportswear giant to...
BMW is navigating a period of significant strategic activity, marked by a simultaneous leadership transition and a major product offensive....
Arafura Rare Earths finds itself at a pivotal juncture, with multiple strategic developments aligning as it advances its flagship Nolans...
While Valneva has reviewed its 2025 financial results and confirmed guidance for 2026, the company’s focus remains singularly fixed on...
A significant portfolio adjustment is taking effect for the Vanguard FTSE All-World UCITS ETF (USD Accumulation). As of the market...
Investors in Bremen-based wind farm developer Energiekontor are facing a stark contrast. While the company is accelerating its capacity expansion...
The world’s largest index-tracking fund, the iShares Core MSCI World UCITS ETF USD (Acc), is confronting a complex set of...
Silver Viper Minerals is leveraging a period of consolidation in the silver market to expand its asset base strategically. The...
In a challenging real estate environment, Hamborner REIT is finding resilience by concentrating its investments on a specific retail niche....
The medical technology firm Viromed Medical has appointed a new member to its supervisory board, bringing in seasoned professional Anna...
